You can't put an efficacy result on biological markers, that's what the first study was done on. In other words the study was done on skin tissue. Now, a 70 percent improvement as the company has stated is extremely high for that study. Everyone's efficacy study will be done on actual humans in Phase 2 trials, that's why they are called an efficacy study. That's the study you want to watch, cause it can really move a stock pps upon favorable results, much like phase 2 GWP$ efficacy trial on their epilepsy trial. Google it to get a better understanding of their trials, that's the route OWCP is taking. Then Compare their studies timelines to their stock price. You will see how it went up during certain phases of their phase 2 efficacy trial on humans. That's why I hold a core position here and will continue to because we are heading to that stage of the game this year.
News 
Market Data 
Discover 
